Toggle navigation
About Us
Business Areas
R & D
Manufacturing
Beyond Business
Investors
Careers
Contact Us
Investors
Investors > FY 2020-21
Overview
Chairman's Statement
Shareholder Information
Policies or Statutory Documents
IEPF
Debentures
Amalgamation
MOA/AOA
Procedure for Dematerialisation of Shares
Archives
Credit Ratings
CSR
AGM Transcript
Annual Return
Disclosures under Regulation 46 and 62 of SEBI LODR
Financial
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
2014-15
2013-14
2012-13
2011-12
Investors > FY 2020-21
1. Annual Report
Annual Report 2020-21
Torrent Pharma Inc
Torrent Do Brasil Ltda
Heumann Pharma GmbH & Co
Heunet Pharma GmbH
Torrent Pharma GmbH
Torrent Pharma Philippines Inc
Zao Torrent Pharma
Torrent Pharma S.R.L
Torrent Pharma (UK) Ltd
Laboratorios Torrent, S.A. de C.V
Laboratories Torrent Malaysia Sdn. Bhd
Torrent Australasia Pty. Ltd
Torrent Pharma (Thailand) Co.Ltd
Torrent Pharma France S.A.S
2. Intimation to Stock Exchange
Newspaper Advt of Financial Result for Q4 2020-21
Intimation of Record Date for the purpose of payment of final dividend for the year 2020-21
Intimation for Presentation to analysts on audited financial result for the quarter and year ended 31st March, 2021
Intimation for Concall with Investors / Analyst Q4_2020-21
Shareholding Pattern Q4
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Trading Window Closure
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of interest payment/Redemption date and record date for NCDs issued under ISIN: INE685A07108
Intimation of Schedule of Investors Meet_04-03-2021
Intimation of Schedule of Investors Meet_17-02-2021
Newspaper advertisement of financial result for Q3 2020-21
Intimation for Presentation to analysts on audited financial result for the quarter ended 31st December, 2020
Intimation for Concall with Investors / Analyst Q3_2020-21
Newspaper advertisement for BM Notice_08-02-2021
Shareholding Pattern Q3
Intimation of Board Meeting dated 08-02-2021
Intimation of Record Date
Intimation of Change in Directorate
Intimation for Trading Window Closure
Intimation regarding Issue of Commercial Papers
Partial Redemption of Non-Convertible Debentures issued under ISIN:INE685A07066 & INE685A07082
Payment of Interest & Partial Redemption of Secured Redeemable Non-Convertible Debenture issued under ISIN:INE685A07066 & INE685A07082
Intimation of Credit Rating
Intimation of interest payment/Redemption date and recored date for NCDs issued under ISIN: INE685A07074
Intimation of Schedule of Investors Meet_03-12-2020
Newspaper Advertisement In Respect Of transfer of shares to IEPF
Intimation of Schedule of Investors Meet_23-11-2020
Intimation of Schedule of Investors Meet_19-11-2020
Compliance as per Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for half year ended 30th September, 2020
Newspaper Advertisement of financial result for Q2 2020-21
Intimation for Presentation to analysts on audited financial result for the quarter ended 30th September, 2020
Shareholding pattern Q2
Intimation for Concall with Investor / Analyst Q2_2020-21
Newspaper advertisement for BM Notice_26-10-2020
Intimation of the Board Meeting dated 26-10-2020
Intimation for Trading Window
Intimation of Schedule of Investors Meet under
Intimation of Credit Rating
Shareholding pattern Q1
Result and Scrutinizer’s Report_AGM dated 30-07-2020
Newspaper Advertisement of financial result for Q1 2020-21
Proceedings of 47th Annual General Meeting of the Company held on 30th July, 2020
Intimation for Presentation to analysts on audited financial result for the quarter ended 30th June, 2020
Intimation for Concall with Investor / Analyst Q1_2020-21
Newspaper advertisement for BM Notice 30-07-2020
Intimation of the board meeting dated 30-07-2020
Newspaper advertisement in respect of Annual General Meeting and E-Voting Procedure
Newspaper advertisement regarding Intimation of the 47th AGM of the Company through VC / OAVM facility
Intimation for Trading Window Closure
Newspaper advertisement in respect of the transfer of shares to IEPF
Payment of Interest & Redemption of Secured Redeemable Non-Convertible Debenture issued under ISIN: INE685A07041
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for half year ended 31st March, 2020
Intimation of interest payment/Redemption date and recored date for NCDs issued under ISIN: INE685A07041
Intimation regarding issue of NCDs
Intimation of Credit Rating
Shareholding pattern as on 24-04-2020
Intimation regarding issue of NCDs
Intimation of Credit Rating
Release of encumbered shares of Torrent Pharmaceuticals Limited held by its promoters
3. Quarterly Results
Q1 20-21
Q2 20-21
Q3 20-21
Q4 20-21
Newspaper Advertisement Results Q1
Q1 FY20 Earnings Call - Transcript
Revenue Q1
Press Release Q1
Consolidated Result
Standalone Result
Newspaper Advertisement Results Q2
Q2 FY21 Earnings call Transcript
Press Release Q2
Consolidated Result
Standalone Result
Newspaper Advertisement Results Q3
Q3 FY21 Earnings call Transcript
Consolidated Result
Standalone Result
Press Release Q3
Newspaper Advertisement Results Q4
Q4 FY21 Earnings call Transcript
Press Release Q4
Consolidated Result
Standalone Result
4. Shareholder Communication Tax on Dividend
Shareholder Communication – Tax on Final Dividend
Shareholder Communication – Tax on Dividend
Details of Nodal Officer
Name
: Chintan Trivedi
Designation
: Company Secretary
E-mail Id
: investorservices@torrentpharma.com
IEPF Authority - Refund web page
IEPF Authority - Refund web page >>